Association of Selinexor Dose Reductions With Clinical Outcomes in the BOSTON Study

CONCLUSION: Appropriate dose reductions in response to AEs of the 100 mg selinexor starting dose in the BOSTON study were associated with improved efficacy, reduced AE rates and improved QoL.PMID:37743180 | DOI:10.1016/j.clml.2023.08.018
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research